HLA-B27 AS A RELATIVE RISK FACTOR IN ANKYLOSING ENTHESOPATHY IN TRANSGENIC MICE

被引:52
作者
WEINREICH, S
EULDERINK, F
CAPKOVA, J
PLA, M
GAEDE, K
HEESEMANN, J
VANALPHEN, L
ZURCHER, C
HOEBEHEWRYK, B
KIEVITS, F
IVANYI, P
机构
[1] SSDZ, CTR DIAGNOST, DELFT, NETHERLANDS
[2] INST MOLEC GENET, PRAGUE, CZECH REPUBLIC
[3] INSERM, U93, MOUSE IMMUNOGENET LAB, PARIS, FRANCE
[4] UNIV WURZBURG, INST HYG & MICROBIOL, W-8700 WURZBURG, GERMANY
[5] UNIV AMSTERDAM, ACAD MED CTR, DEPT MED MICROBIOL, 1105 AZ AMSTERDAM, NETHERLANDS
[6] NETHERLANDS ORG APPL SCI RES, INST AGEING & VASC RES, LEIDEN, NETHERLANDS
[7] UNIV AMSTERDAM, ACAD MED CTR, DEPT CELL BIOL & HISTOL, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
10.1016/0198-8859(94)00034-N
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-B27 is a risk factor for several human diseases through a mechanism that is not yet understood. This article describes a naturally occurring joint disease in laboratory mice, ANKENT. ANKENT begins with mild inflammation and culminates in irreversible stiffening of the ankle and/or tarsal joints in one or both hind paws. The macroscopic and histologic features of ANKENT, its relationship to age, gender, and environment, and some immunologic aspects are considered. With respect to genetics, it is demonstrated that an HLA-B27 transgene is a relative risk factor for ANKENT. Its impact depends on the H-2 haplotype, reaching a relative risk value of 9.4 for C57Bl/10, H-2(b) males (P < 0.025). Several features of ANKENT are reminiscent of human AS: joint pathology, age and gender distribution, the presence of non-MHC as well as MHC risk factors (in eluding HLA-B27), and the suspicion that environmental factors are involved.
引用
收藏
页码:103 / 115
页数:13
相关论文
共 27 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]  
BURGOSVARGAS R, 1990, SPINE, V4, P665
[3]  
CHEVALIER X, 1991, J RHEUMATOL, V18, P12
[4]   IMMUNOLOGICAL FUNCTION OF HLA-C ANTIGENS IN HLA-CW3 TRANSGENIC MICE [J].
DILL, O ;
KIEVITS, F ;
KOCH, S ;
IVANYI, P ;
HAMMERLING, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5664-5668
[5]   OPTIMAL DATA-PROCESSING PROCEDURE FOR AUTOMATIC BACTERIAL IDENTIFICATION BY GAS-LIQUID-CHROMATOGRAPHY OF CELLULAR FATTY-ACIDS [J].
EEROLA, E ;
LEHTONEN, OP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (09) :1745-1753
[6]  
EULDERINK F, 1990, ANKYLOSING SPONDYLIT
[7]   EXPRESSION OF A MICROINJECTED PORCINE CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX GENE IN TRANSGENIC MICE [J].
FRELS, WI ;
BLUESTONE, JA ;
HODES, RJ ;
CAPECCHI, MR ;
SINGER, DS .
SCIENCE, 1985, 228 (4699) :577-580
[8]   SPONTANEOUS INFLAMMATORY DISEASE IN TRANSGENIC RATS EXPRESSING HLA-B27 AND HUMAN BETA-2M - AN ANIMAL-MODEL OF HLA-B27-ASSOCIATED HUMAN DISORDERS [J].
HAMMER, RE ;
MAIKA, SD ;
RICHARDSON, JA ;
TANG, JP ;
TAUROG, JD .
CELL, 1990, 63 (05) :1099-1112
[9]   INTERLEUKIN-6 IN SYNOVIAL-FLUID AND SERUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES [J].
HOUSSIAU, FA ;
DEVOGELAER, JP ;
VANDAMME, J ;
DEDEUXCHAISNES, CN ;
VANSNICK, J .
ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :784-788
[10]  
Ivanyi P, 1993, Curr Opin Rheumatol, V5, P436